about
Bacteriophages and their implications on future biotechnology: a reviewHepatitis C virus and neurological damageHost nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinomaPotential mechanisms of hepatitis B virus induced liver injuryHepatitis B virus, HBx mutants and their role in hepatocellular carcinomaComputational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural CompoundsDocking studies of Pakistani HCV NS3 helicase: a possible antiviral drug targetInduced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1Fenofibrate and PBA prevent fatty acid-induced loss of adiponectin receptor and pAMPK in human hepatoma cells and in hepatitis C virus-induced steatosisHepatitis C virus in Pakistan: A systematic review of prevalence, genotypes and risk factorsAbstracts from the 3rd International Genomic Medicine Conference (3rd IGMC 2015) : Jeddah, Kingdom of Saudi Arabia. 30 November - 3 December 2015Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIHRole of Potash Alum in hepatitis C virus transmission at barber's shopHepatitis B virus X protein impedes the DNA repair via its association with transcription factor, TFIIHPrevalence and genotyping of high risk human papillomavirus in cervical cancer samples from Punjab, Pakistan.Unraveling the complex relationship triad between lipids, obesity, and inflammationHepatitis B virus transactivator protein X interacts with the TATA-binding protein.Expression of EBV encoded viral RNA 1, 2 and anti-inflammatory cytokine (interleukin-10) in FFPE lymphoma specimens: a preliminary study for diagnostic implication in PakistanIdentification of ionotrophic purinergic receptors in Huh-7 cells and their response towards structural proteins of HCV genotype 3a.Hepatitis C virus infection: molecular pathways to insulin resistance.Increased phosphoenolpyruvate carboxykinase gene expression and steatosis during hepatitis C virus subgenome replication: role of nonstructural component 5A and CCAAT/enhancer-binding protein β.Prevalence of human immunodeficiency virus infection among transgender men in Rawalpindi (Pakistan).PCR-Based Molecular Diagnosis of Hepatitis Virus (HBV and HDV) in HCV Infected Patients and Their Biochemical StudyHepatitis C virus infection: molecular pathways to metabolic syndrome.A molecular evaluation of dengue virus pathogenesis and its latest vaccine strategies.Dengue fever in the Indian Subcontinent: an overview.An overview: in vitro models of HCV replication in different cell cultures.Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.Oxidative stress and hepatitis C virus.Biomarkers for virus-induced hepatocellular carcinoma (HCC).DNA Mediated Vaccines Delivery Through Nanoparticles.HTLV-1 Associated Neurological Disorders.Design, synthesis, structure information and biochemical activity of new floro substituted organotin(IV) carboxylates.Design, synthesis, and delivery studies of organotin(IV) based HCV inhibitor.Organotin(IV) based anti-HCV drugs: synthesis, characterization and biochemical activity.Nanomaterial Induced Immune Responses and Cytotoxicity.Epigallocatechin-3-gallate inhibits tax-dependent activation of nuclear factor kappa B and of matrix metalloproteinase 9 in human T-cell lymphotropic virus-1 positive leukemia cells.Comparison of structural architecture of HCV NS3 genotype 1 versus Pakistani genotype 3a.Additional glycosylation within a specific hypervariable region of subtype 3a of hepatitis C virus protects against virus neutralization.
P50
Q21245088-C5693A45-D656-4056-A39C-053F7C030566Q26748575-6B3D3FF7-EB0C-4947-9955-E28944A2B2EDQ26750792-673ABED1-D0FC-4E98-B556-773FE0C9EEBEQ27014079-4B1A5F57-F78F-4BB8-90C5-77BDBCEA7E1AQ27024874-AC3DDFB7-7E44-4011-9222-2EB7CD0928EFQ27307600-F05F77F5-6ACF-4B21-A122-6363223AC8BBQ27313291-F6F8C416-271A-4BF2-8376-4E885EA28E86Q27471632-0DCD3FB0-3E5C-4673-8DEA-B9D833A31806Q27489896-31EA7418-2DA1-462F-A54D-5CF16595202DQ27490493-2261B8D0-B4A3-441A-83C1-2AAF2042B3E6Q28552866-71DC9976-FCC5-42C9-98EF-8545127EA861Q28569202-1A1B3CB2-7157-4456-A860-EC4120877FC2Q28573627-6DB797FC-9B4D-4652-ABC4-9324A4AC8072Q28743731-1D83307E-4439-42AB-AFFD-812E72AA131DQ33837409-3EA8FBB8-8132-4C40-B06B-AA88B74CC576Q33963437-1D350913-3201-450F-92F8-D01491ECD5EEQ34042152-5DD93D24-196F-4A9F-A90B-DBD7D3CA38F8Q34673509-5092C77E-0BF4-47AD-97F2-C21703AFE1BAQ35168623-8F62E28B-CFF5-46D1-87B2-B1FCE5807EE2Q35225996-3C69462B-D2C5-4944-86D2-BD3A70AB5377Q35505394-EA013671-A5CB-4133-94C2-FFF21CE4E18EQ36347839-1972CBDA-A061-4F3C-BF5A-887B5D409A02Q36572183-902953BA-3A16-4852-AF40-E1D2DD9DEE54Q37018799-284B09AE-4895-44D1-B0A0-07CBDE08C480Q37151026-84455467-AC97-425B-816F-66F30873E857Q37812291-A4D52292-B42A-425A-9CAF-C73269270C73Q37871255-523ECC57-BD5A-4CB0-AA6F-C25011A5A43CQ37953614-22919880-43AC-4342-B317-431EAD7B09F0Q38119830-16A268D3-E0DE-4828-BB4D-9DE6781F27F3Q38127242-FDB30502-6ADA-4B15-A06C-8BC0B73045CBQ38222528-8E6FD09C-1CA0-4003-B20D-E05B2E2E2622Q38578212-1AC1D5E9-457B-4D1F-AA33-DF2EEDC75AA2Q38778296-C815BB20-D6EB-4F02-86E6-A1DB75E5EEBEQ38808770-1ECE6BFA-45A2-4FFC-8752-72F656028604Q38838474-0EA54201-BA56-4F98-8CAC-F3123C4B083AQ38874479-59A825C6-04D3-4793-A3EA-E8166DB53CF2Q38891942-070403C1-97B4-41A2-8A7F-0D766D4323EAQ39017624-B5DA96B1-1B42-48A1-B0D7-4A64B0B87021Q39097394-531A8F27-FDC2-4817-9861-C79BE3BF1D87Q39116632-83C5050A-6303-4043-8A19-FE6565DA3661
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ishtiaq Qadri
@ast
Ishtiaq Qadri
@en
Ishtiaq Qadri
@es
Ishtiaq Qadri
@nl
type
label
Ishtiaq Qadri
@ast
Ishtiaq Qadri
@en
Ishtiaq Qadri
@es
Ishtiaq Qadri
@nl
prefLabel
Ishtiaq Qadri
@ast
Ishtiaq Qadri
@en
Ishtiaq Qadri
@es
Ishtiaq Qadri
@nl
P106
P31
P496
0000-0003-4334-0585